Duloxetine in the management of chronic musculoskeletal pain

References

• AltmanRDSmithHSOpioid therapy for osteoarthritis and chronic low back painPostgrad Med20101226879721084785
   PubMed Web of Science ®Google Scholar
• BradenJBFanMYEdlundMJMartinBCDeVriesASullivanMDTrends in use of opioids by noncancer pain type 2000–2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP studyJ Pain20089111026103518676205
   PubMed Web of Science ®Google Scholar
• SullivanMDEdlundMJFanMYDeVriesABradenJBMartinBCTrends in use of opioids for non-cancer pain conditions 2000–2005 in commercial and Medicaid insurance plans: the TROUP studyPain2008138244044918547726
   PubMed Web of Science ®Google Scholar
• ChanKWNgaiHYIpKKLamKHLaiWWCo-morbidities of patients with knee osteoarthritisHong Kong Med J200915316817219494370
   PubMedGoogle Scholar
• ReeuwijkKGde RooijMvan DijkGMVeenhofCSteuktjensMPDekkerJOsteoarthritis of the hip or knee: which coexisting disorders are disabling?Clin Rheumatol201029773974720177725
   PubMed Web of Science ®Google Scholar
• BowerWAJohnsMMargolisHSWilliamsITBellBPPopulation-based surveillance for acute liver failureAm J Gastroenterol2007102112459246317608778
   PubMed Web of Science ®Google Scholar
• ChunLJTongMJBusuttilRWHiattJRAcetaminophen hepatotoxicity and acute liver failureJ Clin Gastroenterol200943434234919169150
   PubMed Web of Science ®Google Scholar
• LeeCStrausWLBalshawRBarlasSVogelSSchnitzerTJA comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysisArthritis Rheum200451574675415478167
   PubMed Web of Science ®Google Scholar
• WatkinsPBKaplowitzNSlatteryJTAminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trialJAMA20062961879316820551
   PubMed Web of Science ®Google Scholar
• PuenpatomRAVictorTWIncreased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III dataPostgrad Med2009121692019940413
   PubMed Web of Science ®Google Scholar
• ChouRQaseemASnowVDiagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain SocietyAnn Intern Med2007147747849117909209
   PubMed Web of Science ®Google Scholar
• Institute for Clinical Systems ImprovementAdult Low Back PainBloomington, MNInstitute for Clinical Systems Improvement2008
   Google Scholar
• Michigan Quality Improvement ConsortiumManagement of Acute Low Back PainSouthfield, MIMichigan Quality Improvement Consortium2008
   Google Scholar
• National Collaborating Centre for Chronic ConditionsOsteoarthritis: The Care and Management of Osteoarthritis in AdultsLondonRoyal College of Physicians2008
   Google Scholar
• ZhangWDohertyMLeebBFEULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)Ann Rheum Dis200766337738817046965
   PubMed Web of Science ®Google Scholar
• ZhangWMoskowitzRWNukiGOARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelinesOsteoarthritis Cartilage200816213716218279766
   PubMed Web of Science ®Google Scholar
• ChouRShekellePWill this patient develop persistent disabling low back pain?JAMA2010303131295130220371789
   PubMed Web of Science ®Google Scholar
• TowheedTEMaxwellLJuddMGCattonMHochbergMCWellsGAcetaminophen for osteoarthritisCochrane Database Syst Rev20061CD00425716437479
   PubMed Web of Science ®Google Scholar
• KuehnBMFDA focuses on drugs and liver damage: labeling and other changes for acetaminophenJAMA2009302436937119622807
   PubMed Web of Science ®Google Scholar
• BjordalJMLjunggrenAEKlovningASlordalLNon-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trialsBMJ20043297478131715561731
   PubMed Web of Science ®Google Scholar
• FendrickAMGreenbergBPA review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritisOsteopath Med Prim Care20093119126235
   PubMedGoogle Scholar
• Hippisley-CoxJCouplandCLoganRRisk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysisBMJ200533175281310131616322018
   PubMed Web of Science ®Google Scholar
• KearneyPMBaigentCGodwinJHallsHEmbersonJRPatronoCDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ200633275531302130816740558
   PubMed Web of Science ®Google Scholar
• EvansJMMcGregorEMcMahonADNon-steroidal anti-inflammatory drugs and hospitalization for acute renal failureQJM19958885515577648241
   PubMed Web of Science ®Google Scholar
• AntmanEMBennettJSDaughertyAUse of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart AssociationCirculation2007115121634164217325246
   PubMed Web of Science ®Google Scholar
• CheethamTCLevyGNiuFBixlerFGastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase- 2 inhibitors in patients on warfarinAnn Pharmacother200943111765177319809010
   PubMed Web of Science ®Google Scholar
• FarkouhMEGreenbergJDJegerRVCardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxibAnn Rheum Dis200766676477017412741
   PubMed Web of Science ®Google Scholar
• American Geriatrics SocietyPanel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older personsJ Am Geriatr Soc20095781331134619573219
   PubMed Web of Science ®Google Scholar
• KienzlerJLGoldMNollevauxFSystemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteersJ Clin Pharmacol2010501506119841157
   PubMed Web of Science ®Google Scholar
• AltmanRDDreiserRLFisherCLChaseWFDreherDSZacherJDiclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trialJ Rheumatol20093691991199919648310
   PubMed Web of Science ®Google Scholar
• BarthelHRHaselwoodDLongleyS3rdGoldMSAltmanRDRandomized controlled trial of diclofenac sodium gel in knee osteoarthritisSemin Arthritis Rheum200939320321219932833
   PubMed Web of Science ®Google Scholar
• SimonLSGriersonLMNaseerZBookmanAAZev ShainhouseJEfficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritisPain2009143323824519380203
   PubMed Web of Science ®Google Scholar
• BarafHSGoldMSClarkMBAltmanRDSafety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trialPhys Sportsmed2010382192820631460
   PubMed Web of Science ®Google Scholar
• SinghGFortJGGoldsteinJLCelecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I StudyAm J Med2006119325526616490472
   PubMed Web of Science ®Google Scholar
• LIDODERM, lidocaine path 5% [package insert]Chadds Ford, PAEndo Pharmaceuticals2010
   Google Scholar
• GammaitoniARGalerBSOnawolaRJensenMPArgoffCELidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain ScaleCurr Med Res Opin200420Suppl 2S131915563742
   PubMed Web of Science ®Google Scholar
• KivitzAFairfaxMSheldonEAComparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adultsClin Ther200830122366237719167595
   PubMed Web of Science ®Google Scholar
• ArgoffCEGalerBSJensenMPOlekaNGammaitoniAREffectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain ScaleCurr Med Res Opin200420Suppl 2S212815563743
   PubMed Web of Science ®Google Scholar
• GalerBSGammaitoniAROlekaNJensenMPArgoffCEUse of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back painCurr Med Res Opin200420Suppl 2S51215563741
   PubMed Web of Science ®Google Scholar
• GimbelJLinnRHaleMNicholsonBLidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot studyAm J Ther200512431131916041194
   PubMedGoogle Scholar
• EthgenOBruyereORichyFDardennesCReginsterJYHealth-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literatureJ Bone Joint Surg Am200486-A596397415118039
   PubMed Web of Science ®Google Scholar
• VirolainenPAroHTHigh tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studiesArch Orthop Trauma Surg2004124425826112827394
   PubMed Web of Science ®Google Scholar
• BravoCJRizzoMHormelKBBeckenbaughRDPyrolytic carbon proximal interphalangeal joint arthroplasty: results with minimum two-year follow-up evaluationJ Hand Surg Am200732111117218170
   PubMed Web of Science ®Google Scholar
• FieldJTwo to five year follow-up of the LPM ceramic coated proximal interphalangeal joint arthroplastyJ Hand Surg Eur Vol2008331384418332018
   PubMed Web of Science ®Google Scholar
• PattSMcDiarmidTTramadol addictionJ Fam Pract200554435615833228
   PubMed Web of Science ®Google Scholar
• PolliceRCasacchiaMBianchiniVMazzaMContiCMRonconeRSevere tramadol addiction in a 61 year-old woman without a history of substance abuseInt J Immunopathol Pharmacol200821247547618547496
   PubMed Web of Science ®Google Scholar
• WoodyGESenayECGellerAAn independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride)Drug Alcohol Depend200372216316814636971
   PubMed Web of Science ®Google Scholar
• InciardiJACiceroTJMunozAThe diversion of Ultram, Ultracet, and generic tramadol HCLJ Addict Dis2006252535816785220
   PubMed Web of Science ®Google Scholar
• CiceroTJInciardiJAAdamsEHRates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994–2004Pharmacoepidemiol Drug Saf2005141285185915892169
   PubMed Web of Science ®Google Scholar
• SenayECAdamsEHGellerAPhysical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occurDrug Alcohol Depend200369323324112633909
   PubMed Web of Science ®Google Scholar
• LanierRKLofwallMRMintzerMZBigelowGEStrainECPhysical dependence potential of daily tramadol dosing in humansPsychopharmacology (Berl)2010211445746620589494
   PubMed Web of Science ®Google Scholar
• ZhangWNukiGMoskowitzRWOARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009Osteoarthritis Cartilage201018447649920170770
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Primary CareLow Back Pain Early Management of Persistent Non-specific Low Back PainLondonRoyal College of Physicians2009
   Google Scholar
• AiraksinenOBroxJICedraschiCChapter 4. European guidelines for the management of chronic nonspecific low back painEur Spine J200615Suppl 2S19230016550448
   PubMed Web of Science ®Google Scholar
• SmithHSBarkinRLFibromyalgia syndrome: a discussion of the syndrome and pharmacotherapyAm Ther2010174418439
   PubMed Web of Science ®Google Scholar
• StahlSMGradyMMMoretCBrileyMSNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressantsCNS Spectr200510973274716142213
   PubMed Web of Science ®Google Scholar
• HanstenPDHornJRThe Top 100 Drug Interactions: A Guide to Patient ManagementFreeland, WAH&H Publications LLP2010
   Google Scholar
• KnadlerMPLoboEChappellJBergstromRDuloxetine: clinical pharmacokinetics and drug interactionsClin Pharmacokinet201150528129421366359
   PubMed Web of Science ®Google Scholar
• WickershamRMDrug facts and comparisonsE-answers Wolter KluwerHealth Inc Referred2010
   Google Scholar
• BarkinRLDuloxetine: a pharmacological overviewPain Med Network200722811
   Google Scholar
• CurranMPDuloxetine: in patients with fibromyalgiaDrugs20096991217122719537838
   PubMed Web of Science ®Google Scholar
• RellingMVLinJSAyersGDEvansWERacial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activitiesClin Pharmacol Ther19925266436581458773
   PubMed Web of Science ®Google Scholar
• SchrenkDBrockmeierDMorikeKBockKWEichelbaumMA distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteersEur J Clin Pharmacol19985353613679516038
   PubMed Web of Science ®Google Scholar
• MeasePJHannaSFrakesEPAltmanRDPain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatmentJ Rheumatol20113881546155121632678
   PubMed Web of Science ®Google Scholar
• LeeYCNassikasNJClauwDJThe role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgiaArthritis Res Ther201113221121542893
   PubMed Web of Science ®Google Scholar
• FarrellMJGibsonSJMcMeekenJMHelmeRDIncreased movement pain in osteoarthritis of the hands is associated with A beta-mediated cutaneous mechanical sensitivityJ Pain20001322924214622622
   PubMed Web of Science ®Google Scholar
• WesselJThe reliability and validity of pain threshold measurements in osteoarthritis of the kneeScand J Rheumatol19952442382427481589
   PubMed Web of Science ®Google Scholar
• Arendt-NielsenLNieHLaursenMBSensitization in patients with painful knee osteoarthritisPain2010149357358120418016
   PubMed Web of Science ®Google Scholar
• GwilymSEKeltnerJRWarnabyCEPsychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patientsArthritis Rheum20096191226123419714588
   PubMed Web of Science ®Google Scholar
• O’DriscollSLJaysonMIPain threshold analysis in patients with osteoarthrosis of hipBr Med J1974359337147154414976
   PubMed Web of Science ®Google Scholar
• KosekEOrdebergGLack of pressure pain modulation by heterotopic noxious conditioning stimulation in patients with painful osteoarthritis before, but not following, surgical pain reliefPain2000881697811098101
   PubMed Web of Science ®Google Scholar
• BajajPBajajPGraven-NielsenTArendt-NielsenLOsteoarthritis and its association with muscle hyperalgesia: an experimental controlled studyPain200193210711411427321
   PubMed Web of Science ®Google Scholar
• SkljarevskiVOssannaMLiu-SeifertHA double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back painEur J Neurol20091691041104819469829
   PubMed Web of Science ®Google Scholar
• SkljarevskiVDesaiahDLiu-SeifertHEfficacy and safety of duloxetine in patients with chronic low back painSpine (Phila Pa 1976)20103513E57858520461028
   PubMed Web of Science ®Google Scholar
• SkljarevskiVZhangSDesaiahDDuloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trialJ Pain201011121282129020472510
   PubMed Web of Science ®Google Scholar
• KarpJFWeinerDKDewMABegleyAMillerMDReynoldsCF3rdDuloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot studyInt J Geriatr Psychiatry201025663364219750557
   PubMed Web of Science ®Google Scholar
• ChappellASOssannaMJLiu-SeifertHDuloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trialPain2009146325326019625125
   PubMed Web of Science ®Google Scholar
• ChappellASDesaiahDLiu-SeifertHA double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the kneePain Pract2011111334120602715
   PubMed Web of Science ®Google Scholar
• HochbergMCWohlreichMGaynorPHannaSRisserRClinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritisJ Rheumatol201239235235822133624
   PubMed Web of Science ®Google Scholar
• SullivanMDBentleySFanMYGardnerGA single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis painJ Pain200910220821318976962
   PubMed Web of Science ®Google Scholar
• WaniZADharSAButtMFRatherYHSheikhSDuloxetine in treatment of refractory chronic tennis elbow: two case reportsJ Med Case Reports20082305
   PubMedGoogle Scholar
• BruntonSWangFEdwardsSBProfile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studiesDrug Saf201033539340720397739
   PubMed Web of Science ®Google Scholar
• Cymbalta^® full prescribing information; data on file with Lily Research Laboratories2011
   Google Scholar
• FrakesEPRisserRCBallTDHochbergMCWohlreichMMDuloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trialCurr Med Res Opin201127122361237222017192
   PubMed Web of Science ®Google Scholar
• HochmanJRFrenchMRBerminghamSLHawkerGAThe nerve of osteoarthritis painArthritis Care Res (Hoboken)20106271019102320589688
   PubMed Web of Science ®Google Scholar
• BeckweeDDe HertoghWLievensPBautmansIVaesPEffect of TENS on pain in relation to central sensitization in patients with osteoarthritis of the knee: study protocol for a randomized controlled trialTrials20121312122353582
   PubMed Web of Science ®Google Scholar
• YarnitzkyDGranotMMahman-AverbuchHKhamaisiMGranovskyYConditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathyPain201215361193119822480803
   PubMed Web of Science ®Google Scholar